Patents by Inventor Matthew Kyle Fuld

Matthew Kyle Fuld has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Photon counting computed tomography using a combination of contrast agents for simultaneous visualization of anatomy and a plurality of materials
    Patent number: 10165995
    Abstract: A method for performing Photon Counting Computed Tomography (PCCT) using a combination of contrast agents includes configuring a PCCT device with a plurality of threshold values corresponding to a plurality of contrast agents. These contrast agents comprise a long-acting blood pool contrast agent and a nanoparticle contrast agent. The PCCT device is used to perform an imaging scan on an anatomical subject in the presence of the plurality of contrast agents to acquire image data. Next, the imaging data is processed into a plurality of datasets based on the plurality of threshold values. The datasets comprise a first dataset corresponding to the long-acting blood pool contrast agent, and a second dataset corresponding to the nanoparticle contrast agent.
    Type: Grant
    Filed: April 16, 2015
    Date of Patent: January 1, 2019
    Assignee: Siemens Healthcare GmbH
    Inventors: Christian D. Eusemann, Matthew Kyle Fuld
  • PHOTON COUNTING COMPUTED TOMOGRAPHY USING A COMBINATION OF CONTRAST AGENTS FOR SIMULTANEOUS VISUALIZATION OF ANATOMY AND A PLURALITY OF MATERIALS
    Publication number: 20170020472
    Abstract: A method for performing Photon Counting Computed Tomography (PCCT) using a combination of contrast agents includes configuring a PCCT device with a plurality of threshold values corresponding to a plurality of contrast agents. These contrast agents comprise a long-acting blood pool contrast agent and a nanoparticle contrast agent. The PCCT device is used to perform an imaging scan on an anatomical subject in the presence of the plurality of contrast agents to acquire image data. Next, the imaging data is processed into a plurality of datasets based on the plurality of threshold values. The datasets comprise a first dataset corresponding to the long-acting blood pool contrast agent, and a second dataset corresponding to the nanoparticle contrast agent.
    Type: Application
    Filed: April 16, 2015
    Publication date: January 26, 2017
    Inventors: Christian D. Eusemann, Matthew Kyle Fuld